Clinical characteristics and outcomes of the multisystem inflammatory syndrome in children (MIS-C) following COVID-19 infection in Iran: A multicenter study.

Clinical characteristics and outcomes of the multisystem inflammatory syndrome in children (MIS-C) following COVID-19 infection in Iran: A multicenter study.

<h4>Objectives</h4>This study aimed to assess the clinical characteristics, treatment and outcomes of the multisystem inflammatory syndrome in children (MIS-C) following COVID-19 in five different geographical regions of Iran.<h4>Methods</h4>In this multicenter observational...

Full description

Bibliographic Details
Main Authors:	Fereshteh Rostami-Maskopaee, Fani Ladomenou, Seyedeh-Kiana Razavi-Amoli, Mohammad Reza Navaeifar, Azin Hajialibeig, Leila Shahbaznejad, Fatemeh Hosseinzadeh, Behzad Haghighi Aski, Ali Manafi Anari, Mohsen Mohammadi, Mohammad Bagher Rahmati, Eslam Shorafa, Seyedenarjes Abootalebi, Mohammad Sadegh Rezai
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0274104

Similar Items

Gastrointestinal Features of the Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19 Infection in Selected Referral Hospitals in Iran
by: Fereshteh Rostami-Maskopaee, et al.
Published: (2023-04-01)

Multisystem Inflammatory Syndrome Mortality Following COVID-19 in Iranian Children: A Case Series and Literature Review
by: Mohammad Sadegh Rezai, et al.
Published: (2023-07-01)

Diagnosis and Treatment of Multisystem Inflammatory Syndrome Following COVID-19 in Children
by: Leila Shahbaznejad, et al.
Published: (2021-09-01)

Clinical Manifestations of Multisystem Inflammatory Syndrome in Children Following COVID-19: A Narrative Review
by: Leila Shahbaznejad, et al.
Published: (2021-10-01)

Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran
by: Leila Shahbaznejad, et al.
Published: (2020-11-01)

COVID-19 in Pediatric Granulomatosis with Polyangiitis
by: Amir Saeed, et al.
Published: (2021-01-01)

Obstructive Renal Failure Caused by Bilateral Renal Candidiasis and Hypoplastic Renal Pelvises in a Preterm Infant: Case Presentation and Review of the Literature
by: Farhad Abolhassan Choobdar, et al.
Published: (2016-12-01)

Invasive and Non-invasive Mechanical Ventilation in Pediatric Patients with COVID-19: A Systematic Review
by: Mohammad Reza Navaeifar, et al.
Published: (2020-10-01)

Unusual presentation of miliary tuberculosis in a 12-year-old girl: a case report
by: Mahsa Kamali, et al.
Published: (2024-04-01)

Epidemiological and Clinical Characteristics of Kawasaki Disease in Mazandaran
by: Mahboube Jafari Sarouei, et al.
Published: (2022-09-01)

The Youngest Palestinian Case of Multisystem Inflammatory Syndrome in children (MIS-C)
by: Fawzy Mazen Abunejma, et al.
Published: (2022-12-01)

Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials
by: Mohammad Sadegh Rezai, et al.
Published: (2022-06-01)

Multisystem inflammatory syndrome in children (MIS-C) and “Near MIS-C”: A continuum?
by: Sarah Khafaja, et al.
Published: (2023-01-01)

Multisystem inflammatory syndrome associated with coronavirus disease 2019: MIS-C-concepts and MIS-concepts
by: Pradeep Kumar Sharma
Published: (2021-01-01)

Multisystem inflammatory syndrome in children (MIS-C) and long Covid
by: Yonca Bulut
Published: (2024-03-01)

Multisystem inflammatory syndrome in children (MIS-C) post-COVID-19 in Iran: clinical profile, cardiac features, and outcomes
by: Ali Hoseininasab, et al.
Published: (2024-03-01)

Innate immune dysregulation in multisystem inflammatory syndrome in children (MIS-C)
by: Johana Isaza-Correa, et al.
Published: (2023-09-01)

30 Multisystem inflammatory syndrome in children (MIS-C/PIMS): an overview
by: Eunice Jia Lin Tang
Published: (2021-04-01)

The Role of Glucocorticoids in the Treatment of Multisystem Inflammatory Syndrome (MIS-C)—Data from POLISH MIS-C Registry
by: Ewelina Gowin, et al.
Published: (2022-02-01)

Intravenous Immunoglobulin Resistant Kawasaki Disease
by: Mohammad Reza Navaeifar, et al.
Published: (2013-01-01)

Device associated nosocomial infection in children
by: Mohammad Reza Navaeifar, et al.
Published: (2013-05-01)

Assessing Safety Status of Pediatric Intensive Care Units of Tehran, Iran according to the World Health Organization’s Safety Standards
by: Fatemeh Kalroozi, et al.
Published: (2022-05-01)

A critical analysis of Iran health system reform plan
by: Fatemeh Kalroozi, et al.
Published: (2020-01-01)

MULTISYSTEM-INFLAMMATORY SYNDROME (MIS-C) IN NEONATE ASSOCIATED WITH SARS-COVID19
by: Yerdan Mukhaliyev, et al.
Published: (2022-06-01)

MULTISYSTEM-INFLAMMATORY SYNDROME (MIS-C) IN NEONATE ASSOCIATED WITH SARS-COVID19
by: Yerdan Mukhaliyev, et al.
Published: (2022-06-01)

Multisystem Inflammatory Syndrome in an Adult (MIS-A) Successfully Treated with Anakinra and Glucocorticoids
by: Paolo Cattaneo, et al.
Published: (2021-06-01)

Incidence and Prevalence of Multisystem Inflammatory Syndrome in Children (MIS-C) in Southern Italy
by: Francesco La Torre, et al.
Published: (2023-04-01)

Cardiac Involvement in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in Poland
by: Kamila M. Ludwikowska, et al.
Published: (2023-04-01)

Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable?
by: Istemi Serin, et al.
Published: (2022-03-01)

The “Golden Hours” Algorithm For the Management of the Multisystem Inflammatory Syndrome in Children (MIS-C)
by: Sanaa Mahmoud MD, PhD, et al.
Published: (2021-01-01)

The Role of Therapeutic Plasma Exchange (TPE) in Multisystem Inflammatory Syndrome in Children (MIS-C)
by: Gurkan Atay, et al.
Published: (2021-06-01)

Outpatient monitoring of patients with multisystem inflammatory syndrome (MIS-C): A mini review
by: Jerin Tresa Jose, et al.
Published: (2022-12-01)

Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
by: Şengül Çaǧlayan, et al.
Published: (2022-08-01)

Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) in a Middle Eastern patient cohort
by: Lemis Yavuz, et al.
Published: (2023-06-01)

Terminal ileitis and cytotoxic lesion of corpus callosum as the presenting features of Multisystem inflammatory syndrome in children (MIS-C): a case report
by: Marzieh Davoodi, et al.
Published: (2023-01-01)

Concomitant Cytomegalovirus Viraemia in Multisystem Inflammatory Syndrome in Adults (MIS-A) following COVID-19
by: Benjamin Valente-Acosta, et al.
Published: (2024-01-01)

Lung Ultrasound Patterns in Multisystem Inflammatory Syndrome in Children (MIS-C)-Characteristics and Prognostic Value
by: Anna Camporesi, et al.
Published: (2022-06-01)

Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
by: Dominic Worku
Published: (2023-03-01)

355 Unraveling and targeting the innate immune response in Multisystem Inflammatory Syndrome in Children (MIS-C)
by: Jenna K Dick, et al.
Published: (2023-04-01)

Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19
by: Benhur Sirvan Cetin, et al.
Published: (2022-06-01)